Frontier Scientific is developing and supplying an Active Pharmaceutical Ingredient production process for clinical trial of investigational COVID-19 therapeutic drug RBT-9
―Renibus Therapeutics will conduct a Phase 2 trial of a compound with antiviral and immunomodulatory…
